Dyslipidaemia is a major contributor to the onset of metabolic disease. Here, Meikle and Summers discuss lipidomic research into relationships between diet, lipid metabolism and metabolic disease. The Review also highlights promising potential therapeutics that target lipid metabolism to counteract obesity, insulin resistance and type 2 diabetes mellitus.
- Peter J. Meikle
- Scott A. Summers